• Angiotensin 1/2 (1-6): Assay-First Biology

  2026-08-27

  Explore Angiotensin 1/2 (1-6), the Asp-Arg-Val-Tyr-Ile-His hexapeptide, through an assay-first framework that connects renin-angiotensin system research with cardiovascular and renal biology. Learn how recent binding evidence should shape controls, peptide comparisons, and cross-domain interpretation.

• Ro 3306: A Checkpoint-Aware CDK1 Assay Strategy

  2026-08-27

  Ro 3306 is a selective CDK1 inhibitor for controlled G2/M arrest, cancer cell synchronization, and DNA repair studies. This guide adds a phase-aware framework that connects CDK1 inhibition with mTORC1 state, checkpoint biology, and assay interpretation.

• Indole-3-pyruvic acid: Assay Workflows

  2026-08-26

  Indole-3-pyruvic acid (IPA) connects plant auxin biosynthesis with AhR-focused immune assays. This practical guide shows how to plan IPA experiments, select controls, translate the rheumatoid arthritis findings into workflows, and troubleshoot exposure, viability, and pathway-specific readouts.

• Tauroursodeoxycholic Acid for ER Stress Workflows

  2026-08-26

  Tauroursodeoxycholic Acid, or TUDCA, gives researchers a practical chemical-chaperone approach for separating ER stress, mitochondrial injury, inflammation, and apoptosis in cell and tissue models. This workflow translates recent subarachnoid hemorrhage findings into assay-ready experiments while emphasizing dose control, orthogonal validation, and troubleshooting.

• O-GlcNAcylation Rewires Wnt Bone Formation

  2026-08-25

  The reference study identifies O-GlcNAcylation as a key metabolic effector of Wnt-stimulated osteoblastogenesis. It shows that Wnt3a links calcium and β-catenin signaling to PDK1 stabilization, aerobic glycolysis, bone formation, and fracture healing, providing a mechanistic framework for studying anabolic Wnt biology.

• MEHP, AhR, and Ovarian Follicle Toxicity

  2026-08-25

  A 2024 Biology of Reproduction study identifies aryl hydrocarbon receptor activation as a functional mediator of mono(2-ethylhexyl) phthalate toxicity in mouse ovarian antral follicles. Pharmacological blockade with CH223191 partially restored follicle growth, estrogen production, and estrogen-responsive gene expression, linking AhR activity to reproductive disruption.

• Phosbind Acrylamide: Reading Cold Signaling

  2026-08-24

  Phosbind Acrylamide enables antibody-independent protein phosphorylation analysis through phosphate-sensitive mobility shifts in SDS-PAGE. This article applies that assay logic to the calcium-feedback architecture of apple cold signaling and clarifies what gel shifts can—and cannot—prove.

• BMAL1 Phase Separation and Circadian Transcription

  2026-08-24

  Gao et al. show that BMAL1 forms phosphorylation-sensitive nuclear condensates that function as transcriptional hubs rather than acting only as a conventional DNA-binding factor. An N-terminal intrinsically disordered region is required for these assemblies and for restoration of circadian transcription and locomotor rhythms, linking spatial protein organization to clock function.

• BEND Lipids for mRNA Delivery and Gene Editing

  2026-08-23

  The reference study introduces branched endosomal disruptor lipids that improve lipid nanoparticle delivery of mRNA and CRISPR-Cas9 ribonucleoprotein complexes. By combining comparative delivery studies with mechanistic endosomal assays, the authors link terminal lipid branching to enhanced endosomal penetration, hepatic gene editing, and T-cell transfection.

• AM 281 in CB1 Neuropharmacology Workflows

  2026-08-22

  AM 281 provides a selective way to interrogate CB1 signaling in traumatic brain injury, astrocyte glutamate transport, and cognition assays. This workflow-focused guide connects receptor pharmacology with GLT-1, CREB, behavioral, and troubleshooting readouts for more reproducible neuropharmacology research.

• CH 223191 and AhR-Mediated MEHP Ovarian Toxicity

  2026-08-22

  The reference study identifies aryl hydrocarbon receptor activation as a functional contributor to mono(2-ethylhexyl) phthalate-induced defects in mouse ovarian follicles. By combining MEHP exposure with pharmacological AhR blockade, the authors connect receptor activity with impaired follicle growth, estrogen production, and estrogen-responsive gene expression.

• Isoprenaline Hydrochloride in Heart–Brain Research

  2026-08-21

  Isoprenaline Hydrochloride, also known as isoproterenol, is more than a classic cardiac stimulant: it is a controllable perturbation tool for linking β-adrenergic receptor signaling pathway activity with cardiac, vascular, and neurobehavioral phenotypes. This article examines how to deploy it in cardiac arrhythmia research, cardiac conduction disorder models, angiogenesis assays, and emerging heart–brain axis studies while maintaining translational discipline.

• Alternariol Assay Design: From AOH to Fibrosis

  2026-08-20

  Alternariol (AOH) is more than a food-contaminant standard: it is a mechanistic probe linking fungal toxin exposure to xenobiotic metabolism, apoptosis, and hepatic stellate-cell remodeling. This guide presents an assay-centered framework for selecting endpoints, controls, and interpretation strategies.

• Fludarabine DNA Synthesis Inhibitor Workflows

  2026-08-20

  Build more reproducible oncology assays with Fludarabine, from DNA replication and apoptosis measurements to lymphodepletion-informed immune co-cultures. This guide translates its biochemical action and recent antigen-presentation findings into practical workflows for leukemia and multiple myeloma research.

• Dabigatran: Evidence for Thromboembolism Prevention

  2026-08-19

  The 2015 review by Enriquez and colleagues synthesizes pharmacologic, clinical-trial, and safety evidence for dabigatran across atrial fibrillation, venous thromboembolism, and orthopedic prophylaxis. Its practical contribution is a framework for matching a predictable direct-thrombin-inhibitor profile with patient selection, renal function, efficacy endpoints, and bleeding-management strategies.

7866 records 1/525 page Next 12345 下5页 Last page